Review article · 2017
Review articlePublished 2017
Underutilization of Pharmacotherapy for Treatment of Alcohol Use Disorders Part II-Results from a Survey of Practices among North Carolina Mental Health Providers and Brief Review of Efficacy of Available Pharmacotherapies
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: Alcohol is the third leading cause of preventable death worldwide. There is substantial risk for development of alcohol use disorder among those with psychiatric disorders, complicating their care. Despite extensive evidence in support from controlled trials and from expert opinion, medication-assisted treatment has had low levels of penetration in practice. Only 3% of sufferers receive FDA-approved treatment. The goal of this survey is to explore potential causes of underutilization of evidence-based pharmacotherapeutical agents in the treatment of alcohol use. Secondary, we analyze differences in practice patterns between different academic institutions, facilities specializing in chemical dependence treatment, and general community practitioners. We are aware of no prior study that has attempted to evaluate these factors. Methods: An online questionnaire was designed in Qualtrics and distributed through the use of an anonymous link. Target participants were members of the Psychiatry departments of four academic institutions in NC, community mental health providers, prescribers from chemical dependence treatment facilities, and Veteran Affairs psychiatrists. A total of 170 participated, an 85% response rate. Data was analyzed using Qualtrics software as well as by a statistician. Results: A significant portion of psychiatric patients have comorbid alcohol use, and despite patient interest, medications are rarely utilized in both academic as well as chemical dependence facilities-20% of respondents never prescribed any. Reasons mainly include lack of provider knowledge of available medications (r=-0.277, n=136, p=0.001), prescribing guidelines (r=-0.265, n=136, p=0.002) and dosing (r=-0.245, n=136, p=0.004). Provider’s attitude towards substance use treatment also affects prescribing (r=-0.21, n=136, p=0.014). Those who do prescribe seem to favor off-label medications and avoid Naltrexone IM formulation. Providers acknowledge that the majority of those with alcohol use disorders have medical conditions caused or affected by the ongoing use. Instituting medications leads to positive experiences: patients maintain sobriety longer, have less legal problems and are better able to engage in their care. Conclusion: In the treatment of alcohol use, guidelines recommend FDA approved medications in conjunction with bio psychosocial interventions. Global assessment indicates prescribers mainly avoid pharmacotherapy due to lack of comfort and knowledge. There may also be financial barriers in a current alcohol treatment system that is traditionally non-medically oriented. Although it is recommended to start with FDA approved medications, off-label use is high. Despite positive implications noted when medications are instituted, providers’ ambivalence continues. As part of our daily practices, general psychiatrists should gain confidence in using evidence-based, FDA approved, medications in treatment of alcohol use disorders.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 4 Aug 2022
Significance of Pharmacotherapy for Alcohol Addiction
Conference abstract
Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment
Perspective · 29 Aug 2023
Survey of Pharmacotherapy for Tinnitus
Perspective · 23 Feb 2024
Potential Effects of Pharmacotherapy: A Brief Overview
More from this journal
The newest in Journal of Alcoholism & Drug Dependence.
Perspective · 4 Mar 2025
Psychedelic-Assisted Therapy for Alcohol Dependence: Emerging Evidence and Future Directions
Research article · 4 Mar 2025
Genetic and Epigenetic Markers Associated with Alcohol Dependence: A Systematic Analysis
Short communication · 4 Mar 2025
Patterns of Polysubstance Abuse in Urban Populations: Implications for Intervention Strategies
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alcoholism & Drug Dependence
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Cornel N Stanciu”
- BylineArticles whose byline prints “Thomas M Penders”
- BylineArticles whose byline prints “Karl L Wuensch”
- BylineArticles whose byline prints “Joshua Davis”
- BylineArticles whose byline prints “Khalid Elnagar”

